Committee on Infectious Diseases (COID)

The Committee on Infectious Diseases (COID) is committed to supporting the optimal health of all children and adolescents by developing recommendations for diagnostics, treatment, and control measures of infectious diseases. The committee monitors new vaccine licensures and safety data to develop optimal vaccine recommendations; provides guidance on antimicrobial resistance and stewardship, as well as, responds to emerging infectious diseases and/or outbreaks in the United States. This work occurs in three subcommittees: 1. Antimicrobial Resistance and Stewardship, 2. Emerging Infections and Outbreak Response, and 3. Vaccine Policy and Vaccine Hesitancy. These subcommittees reflect the priorities of the committee and were developed in collaboration with internal and external partners.

Vision

To support the optimal health of all children and adolescents by diminishing the adverse health effects of infectious diseases

Mission

To create AAP policies that represent the most current clinical practice for the prevention and treatment of infectious diseases in children and adolescents.

View policy statements

Committee Members

Sean T. O’Leary, MD, MPH, FAAP
Chairperson
Aurora, CO

James D. Campbell, MD, MS, FAAP
Vice Chairperson
Baltimore, MD

Monica I. Ardura, DO, MSCS, FAAP
Columbus, OH

Kristina A Bryant, MD, FAAP
Louisville, KY

Mary T. Caserta, MD, FAAP
Rochester, NY

Claudia M Espinosa, MD, MSc, FAAP
Tampa, FL

Robert W. Frenck Jr. MD, FAAP
Cincinnati, OH

C. Mary Healy, MD, MRCPCH (UK)
Houston, TX

Chandy C. John, MD, MS, FAAP
Indianapolis, IN

Athena P. Kourtis, MD, PhD, MPH, FAAP
Atlanta, GA

Aaron Milstone, MD, FAAP
Baltimore, MD

Angela Myers, MD, MPH, FAAP
Kansas City, MO

Pia Pannaraj, MD, MPH, FAAP
Los Angeles, CA

Adam J. Ratner, MD, MPH, FAAP
New York, NY

Contact COID